Evaluation of the safety and satisfaction of rheumatic patients with accelerated infliximab infusion

Evaluation of the safety and satisfaction of rheumatic patients with accelerated infliximab infusion

Abstract Introduction Infliximab infusion generally occurs in 2–4 h. Recent studies have suggested the possibility of accelerated infusion (1 h) of this drug. Objective To evaluate the safety of accelerated infliximab infusion in patients with rheumatic diseases. In addition, patient satisfaction wa...

Full description

Bibliographic Details
Main Authors: Jozélio Freire de Carvalho, Maria Natividade Pereira dos Santos, Joyce Meyre Vieira de Oliveira, Andrea Nogueira S. Lanty Silva, Roberto Paulo Correia de Araujo, Juliana Bahia Cardozo
Format: Article
Language:English
Published: BMC 2018-08-01
Series:Advances in Rheumatology
Subjects:
Infliximab
Infusion
Immunobiologics
Rheumatoid arthritis
Ankylosing spondylitis
Psoriatic arthritis
Online Access:http://link.springer.com/article/10.1186/s42358-018-0016-x

Internet

http://link.springer.com/article/10.1186/s42358-018-0016-x

Similar Items